A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Clinical trial NCT05020015 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05020015
- Sponsor
- Takeda
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-12
- Primary completion
- 2024-06-16
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.